Selection of a solid-state form is an important decision in development of small molecule API's
Use of Peptides in Anti-Aging Cosmetology
Presentation detailing inhaled products as well as emerging technologies in this area
The aseptic blow-fill-seal (B/F/S) systems have experienced growth.
Softgel Technology as a Lipid-Based Delivery Tool for Bioavailability Enhancement
New strategies in formulation development are helping overcome molecule challenges
Experts present on the ASI™disposable autoinjector platform from Bespak and Catalent
Presentation on ensuring viological safety of biologicals
New study shows superior patient compliance with oral fast dissolve delivery
As the use of “universal” HPLC detectors and charged aerosol detectors become more common
New data shows drug delivery has a positive impact on patient compliance.
An overview of stability studies during drug product lifecycles.
Explore the power of dual detection methods to identify impurties.
Development and validation of a method for determination of bismuth
Development of digestion methods for determination of elemental impurities
Determination of elemental impurities in support of USP <232> and <233>
Disintegration and dissolution characteristics of novel, polysaccharidebased shell softgels
Evaluate the pharmacokinetic behavior of nanosized fenofibrate administered orally
Investigate the relationship between poorly-soluble drugs and disintegration time of (ODTs)
Explore the continuing role of NMR Spectroscopy in characterization of specialty polymers
Absence of evidence is not evidence of absence.
This presentation focuses on improving oral delivery for poorly soluble/permeable drugs.
Proven, acceptable NMR spectroscopy test for common EMAs in raw materials and APIs
Development procedures to reduce antibody effect on Protein Z, with validation results
Determination of residual solvents in API by headspace GC-MS needs multiple analyses
Validate method for determination of extractable & leachable silicone oil
Rapid development model for formulation feasibility & accelerated stability evaluation
Robust options available for micro-dosing inhalation powders with some important caveats
Study investigates design using synthetic molecule recognizing immunoglobulin in serums
Why oral disintegrating tablets are so important to the industry’s oral dose form kit
Study on the impact of emulsion liposomal liquid and lyophilized liposomal formulations.
Effect of a Kollicoat Top-coat on the physical stability of enteric-coated softgels
Advanced cosmeceutical formulation needs with DelPouch® and Vegicaps®
Novel approach to validate a method for the determination of water content
Fish gelatin support of nanoparticle formation of poorly water-solubles during wet milling
General review of Catalent’s new technology that optimizes API and profitability
Validate responsive ELISA for the detection of IPZ in monkey, rat, and human serum fluid
Feasibility of encapsulating the Phosphatidylcholine-based excipients.
Study shows import plasticizer level, & potential for migration from coating to shell
Laser diffraction particle size analysis – a robust and efficient alternative
Method to separate un-derivatized protein Z (uTPZ) from derivatized TPZ in 3 species
New shell and hot-filling that are highly viscous or semi-solid at room temperature
Approach to validate from preclinical development to final commercial implementation
VP of business development discusses blow/fill/seal market and offerings
Del Pouch® adherence package promotes compliance and features media-enhanced packaging.
Catalent experts talk about the increasing demand of prefilled syringes
‘Lean’ is a familiar term in European manufacturing since markets are more competitive
Prefilled Syringes Pinpoint Stability, Compatability, and Safety
Exploration of the largest trends in the prefilled syringe and autoinjection devices
Smarter solutions to improve patient adherence and gain better results
Catelent CEO John Chiminski discusses our offerings
Focuses on new innovation drug delivery devices for patient-administered therapies
Advances in medical discoveries are for nothing if the medicine isn't taken.
Discussion around the latest trends and issues involving solubility.
Catalent executive discusses excellence in compliance in Pharmaceutical Formulation & Quality
This presentation deals with the challenges of using suppliers from around the globe
VP of Corporate Strategy and Development discusses emerging drug-delivery technologies.
This presentation explores market intelligence.
Learn about how talent and technology can help grow a company.
The more efficient a bioassay method transfer, the faster to regulatory submission
Effective brand protection strategy using covert and overt technologies now at Catalent
2009 European study why choosing softgels can impact lifecycle management and marketing
Our innovative packaging solutions that leverage design, efficiency, and security
VP of global sales overviews drug delivery technologies and services as well as key trends
Why companies are looking for partners, how the process works, and looking out for a CRO
Implications of FDA release and responsive technologies available to the manufacturer
How manufacturers can partner with contract packagers in new and increasingly complex ways
Modern healthcare challenges and predictions for pharmaceutical market growth
How to make the decision to outsource, navigate vendor selection, and monitor results
Clinical trials are a critical step in the approval process for new drugs.
Case Study: Marchesini Group for Catalent Pharma Solutions: Efficient Syringe Packaging
This presentation details a case study about a phase III global trial.
From formulation to specialty packaging, this article explores patient adherence.
Explore the issues with technical transfer in regardss to complex pharmaceutical products
Explore a cGMP manufacturing model for reducing operating costs and speeding up drugs to market
The striking efficiency gains Catalent has achieved with the Lean System for Managing
Pros and cons of options, plus discussion of global problems and lack of foreign security
Discover the future of oral Vitamin D3 analogs
Learn steps taken to improve timelines and throughput in generation of mammalian cell lines
Regulatory and global trade requirements for shipment into key clinical trial markets.
Unlocking the therapeutic potential of BCS Type II & IV compounds
Address principles and practices of stability studies in the drug development
Examine the current market, industry trends, and discuss the latest technologies.
An introduction to regulatory documents surrounding leachables and extractables.
A guideline for selecting the best methods to analyze and characterize antibodies.
Explore fit-for-purpose strategies in discovery and development of solid-state forms.
Hot melt extrusion is being explored as a way to overcome solubility challenges.
[Publication Date: 02 20, 2012]
[Publication Date: 02 17, 2012]
[Publication Date: 02 16, 2012]
[Publication Date: 01 30, 2012]
[Publication Date: 01 25, 2012]
Read about Catalent’s latest innovations, expansions, offerings, findings, and more
Munich, Germany 02 28, 2012 - 03 01, 2012
Beijing, China 02 28, 2012 - 02 29, 2012
Philadelphia, PA 03 12, 2012 - 03 23, 2012
Amsterdam, Netherlands 03 19, 2012 - 03 22, 2012
Meet us at events, conferences, and happenings around the globe
Find out about our worldwide facilities
Full-service capabilities across the entire lifecycle of your product
75 years of acquisitions, innovations, global leadership & market success
Meet our world-class team of executive and scientific talent
Catalent's resource library of topical themes and technologies.
Explore our global regulatory compliance and quality management strategies
Welcome to the first annual Life Science Leaders of Tomorrow Global Academic Competition.
Explore how we recruit and train top talent to catalyze our success
Discover the wide range and expertise of the 1,000-plus scientists that make up our team
We take our responsibility to comply with all applicable legal requirements very seriously.
Catalent Pharma Solutions values the privacy of employee and non-employee personal information.
Our commitment to proactively supporting diversity on all levels
Catalent is committed to corporate social responsibility and compliance
Sourcing Center InvestorsCareersContact UsSite Map
Copyright © 2011, Catalent, Inc - All Rights Reserved | Privacy I Terms
